Претрага
Резултати
The IKK2/NF-kappa B pathway suppresses MYC-induced lymphomagenesis [2009]
Klapproth, Kay; Sander, Sandrine; Marinković, Dragan
; Baumann, Bernd; Wirth, Thomas
Non-O Blood Group and Pretreatment Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
[2023]
Otašević, Vladimir ; Ivanović, Jelena ; Vuković, Vojin M. ; Milić, Nataša M. ; Kozarac, Sofija; Pešić, Andrej; Mihaljević, Biljana S. ; Fareed, Jawed; Antić, Darko A.
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease <font color='#0066ff'><strong>(Erratum - errors in Affiliations - vol 118, pg 5767, 2011)</strong></font> [2012]
Zimran, Ari; Brill-Almon, Einat; Chertkoff, Raul; Petakov, Milan S; Blanco-Favela, Francisco; Munoz, Eduardo Terreros; Solorio, Meza Sergio Eduardo; Amato, Dominick J; Duran, Gloria; Giona, Florina;
Heitner, Rene; Rosenbaum, Hanna; Giraldo, Pilar; Mehta, Atul; Park, Glen; Phillips, Mici; Elstein, Deborah; Altarescu, Gheona; Szleifer, Mali; Hashmueli, Sharon; Aviezer, David;
Baseline Characteristics of CML Patients Accross Europe - Comparing Real-World Patients with Patient Collectives Included in Clinical Trials [2014]
Baccarani, Michele; ...; Bogdanovic, Andrija D ; ...; (broj, koautora 36)
Splenic marginal zone cell lymphoma: Clinicopathologic and immunohistochemical evaluation [2002]
Colovic, Milica D; Cemerikic, Vesna M; Colovic, Natasa R ; Terzic, Tatjana T ; Jovcic, NM
Erythropoietin stimulation of isolated human blood vessels and vascular smooth muscle cells.
[2003]
Beleslin-Cokic, Bojana B ; Gojković-Bukarica, Ljiljana C.; Čokić, Vladan P. ; Noguchi, Constance Tom
Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-LenalidomideDexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)
[2023]
Kastritis, Efstathios; ...; Bila, Jelena S. ; ...; Cvetković, Zorica P. ; Marković, Olivera B. ; ...; Sretenović, Aleksandra M.; ...; (broj koautora 20)
Inhibition of Interleukin-6 (IL-6) Reverses Anemia In Patients with Advanced Non Small Cell Lung Cancer (NSCLC): Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial [2010]
Schuster, Michael W; Rigas, James R; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey TOxidative Stress-Mediated Activation of AKT/mTOR Signaling Pathway Leads to Myeloproliferative Syndrome in FoxO3 Null Mice: A Role for Lnk Adaptor Protein [2008]
Yalcin, Safak; Mungamuri, Sathish Kumar; Marinković, Dragan ; Zhang, Xin; Tong, Wei; Cullen, Dana; Ghaffari, Saghi
CELSG CML 11 "ISTAHIT" Phase III Study - Planned Interim Analysis: High Doses of Imatinib Mesylate (800mg/day) Significantly Improve Rates of Major and Complete Cytogenetic Remissions (MCR, CCR) in Pretreated Ph+/BCR-ABL(+) CML Patients in Chronic Phase [2008]
Petzer, Andreas L.; Wolf, Dominik; Fong, Dominic; Bošković, Darinka; Ulmer, Hanno; Gastl, GuentherFilters
By type
- 94